ICD-10 Coding for Bladder Cancer(C67.0, C67.0B, C67.0M)
Explore comprehensive ICD-10 coding guidelines for malignant neoplasm of bladder, including site-specific codes and documentation requirements.
Complete code families applicable to Bladder Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C67.0 | Malignant neoplasm of trigone of bladder | Use when the tumor is specifically located in the trigone of the bladder. |
|
| C67.9 | Malignant neoplasm of bladder, unspecified | Use only when the specific site of the bladder cancer is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBladder Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Bladder Cancer.
Failing to document tumor laterality
Impact
Clinical: Impacts treatment planning and follow-up., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials or reduced reimbursement.
Mitigation
Ensure laterality is documented in all relevant reports.
Using C67.9 when specific site is documented
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Review documentation for specific site and code accordingly.
Unspecified coding
Impact
Frequent use of unspecified codes can trigger audits.
Mitigation
Ensure specific site documentation is reviewed before coding.